Protagonist Therapeutics (PTGX) SEC Filings & 10K Form

$25.15
+0.49 (+1.99%)
(As of 04/26/2024 ET)

Recent Protagonist Therapeutics SEC Filings

DateFilerForm TypeView
04/19/2024
7:05 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:30 PM
Protagonist Therapeutics (Filer)
Form PRE 14A
04/02/2024
7:29 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:45 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:45 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:46 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2024
7:27 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:32 PM
Protagonist Therapeutics (Subject)
Waddill William D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:48 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
7:00 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:02 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:33 PM
Protagonist Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
7:00 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:31 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/14/2024
6:47 AM
Protagonist Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/14/2024
6:15 AM
Point72 Asset Management, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/13/2024
4:12 PM
Protagonist Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/07/2024
6:41 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
02/02/2024
8:19 AM
Farallon Capital Partners, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G/A
01/23/2024
9:55 AM
Protagonist Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/18/2024
7:00 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
7:00 PM
MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
7:01 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
7:00 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:25 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
7:00 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
7:17 PM
Protagonist Therapeutics (Issuer)
Waddill William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:07 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:09 PM
MOLINA ARTURO MD (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:10 PM
Giraudo Bryan (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:11 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:13 PM
Protagonist Therapeutics (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:14 PM
Protagonist Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:15 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:17 PM
O'Dowd Sarah A (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:15 PM
Point72 Asset Management, L.P. (Filed by)
Protagonist Therapeutics (Subject)
Form SC 13G
12/15/2023
3:30 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
4:18 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
3:40 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Protect Yourself While There’s Still Time … (Ad)

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.
10/30/2023
3:30 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
3:30 PM
Protagonist Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/30/2023
3:31 PM
Protagonist Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2023
3:31 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/19/2023
3:55 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
3:13 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
7:00 AM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
3:06 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2023
6:51 PM
Gupta Suneel (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:48 PM
Ali Asif (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2023
6:50 PM
PATEL DINESH V PH D (Reporting)
Protagonist Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
3:20 PM
Protagonist Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:PTGX) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners